Business Wire
BusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex Times
Back to front
Los Angeles jury awards $32 million against Johnson & Johnson in asbestos-tainted talc case
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 10, 11:37 AM EDT

Los Angeles jury awards $32 million against Johnson & Johnson in asbestos-tainted talc case

The verdict stems from a lawsuit alleging pleural mesothelioma caused by years of exposure to asbestos-contaminated talc linked to the company’s baby powder products.

A Los Angeles jury has awarded $32 million to the family of a California woman who died from pleural mesothelioma, according to reporting carried by Yahoo Finance. The case alleges that the woman’s exposure occurred through an asbestos-contaminated talc product sold under the Johnson & Johnson brand, with jurors concluding the company was responsible.

The verdict adds to Johnson & Johnson’s long-running exposure to talc-related litigation, which has focused on whether certain talc used in consumer products was contaminated with asbestos and whether that contamination caused cancers. Pleural mesothelioma is a malignancy associated with asbestos exposure, typically after years of latency.

In related reporting, lawyers have argued to jurors for punitive damages in California talc trials, contending the evidence shows the company knowingly faced risk from its talc supply. One legal report described the Los Angeles matter as part of the growing wave of California bellwether cases, including those seeking to connect Johnson & Johnson’s baby powder to asbestos contamination.

The $32 million award is not the first major talc verdict involving Johnson & Johnson. In March, Reuters reported that a judge threw out a jury’s award directing Johnson & Johnson to pay nearly $1 billion in punitive damages in a prior talc trial, underscoring that outcomes can shift after post-trial motions and appellate review.

Taken together, the verdict and the procedural history illustrate how the talc litigation remains in motion, with juries determining liability and damages while courts later revisit those decisions. For Johnson & Johnson, which has faced thousands of claims, each trial can influence future cases even when individual awards may later be reduced or overturned.

Company and sector context: Johnson & Johnson has repeatedly denied wrongdoing in talc cases and has said it stands by its products and manufacturing. Still, the persistent California trial calendar highlights how state courts have become a key venue for plaintiffs pursuing injury claims tied to talc and asbestos contamination.

What is not disclosed in the Yahoo Finance report is equally important. The article does not spell out the company’s specific trial defenses, whether the verdict included punitive damages on top of compensatory damages, or how the court handled expert testimony, causation evidence, or any evidentiary rulings. Those details typically emerge in later filings and follow-on coverage.

Going forward, investors and industry watchers will likely track whether Johnson & Johnson appeals or seeks post-verdict relief, and whether courts in California continue to treat the case as another bellwether for damages and causation standards. Additional reporting is also likely to clarify how the jury allocated blame and what timeline of exposure the plaintiffs presented.

Why It Matters

  • More trial verdicts can affect the pace and posture of ongoing talc litigation, including settlement leverage and future trial strategies.
  • Even when large jury awards are later challenged, they can shape judicial and juror perceptions about evidence tied to talc sourcing and causation.
  • Procedural outcomes, such as reductions or reversals of punitive damages, can materially change expected costs and risk over time.
  • For Johnson & Johnson, repeated adverse jury decisions keep talc litigation in the spotlight for product-liability risk and corporate reputation.

Sources

Key Facts

  • A Los Angeles jury awarded $32 million to a family in an asbestos-related talc case involving pleural mesothelioma.
  • The reporting says the plaintiff died in 2024 and that the lawsuit alleged exposure to asbestos-contaminated talc in a Johnson & Johnson product.
  • The case was decided in Los Angeles, California.
  • A separate legal-development report described California talc trials as increasingly focused on punitive damages arguments and on alleged asbestos contamination tied to baby powder.
  • Reuters reported that a judge previously threw out a nearly $1 billion punitive damages award against Johnson & Johnson in another talc trial.

Healthcare Related

Los Angeles jury awards $32 million against Johnson & Johnson in asbestos-tainted talc case | The Apex Times